Search Results - "Pongas, Georgios"
-
1
PI3K Signaling Pathway in Normal B Cells and Indolent B Cell Malignancies
Published in Seminars in oncology (01-12-2016)“…In chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHL), B cell receptor signaling leads to activation of the PI3K pathway. Idelalisib, a PI3Kδ…”
Get full text
Journal Article -
2
Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case
Published in Leukemia research reports (2024)“…In the context of chronic lymphocytic leukemia (CLL), Hyperviscosity Syndrome (HVS) typically arises from hyperleukocytosis, although it infrequently stems…”
Get full text
Journal Article -
3
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma
Published in Oncotarget (10-10-2017)“…Cell line models of the activated B cell-like (ABC) subtype of diffuse large B cell (DLBCL) depend on both NF-κB and phosphatidylinositol 3-kinase (PI3K)…”
Get full text
Journal Article -
4
HIV-Associated Lymphomas: Progress and New Challenges
Published in Journal of clinical medicine (07-03-2022)“…The association of human immunodeficiency virus (HIV) and aggressive lymphomas was first reported in 1982. Before the development of effective HIV antiviral…”
Get full text
Journal Article -
5
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
Published in Haematologica (Roma) (08-08-2024)“…Adult T-cell leukemia-lymphoma (ATLL) is an aggressive Human T-cell Leukemia Virus Type 1 (HTLV-1)-driven malignancy. Although Western hemisphere…”
Get full text
Journal Article -
6
Mantle cell lymphoma involving the thyroid gland
Published in Clinical case reports (01-09-2021)“…Mantle cell lymphoma (MCL) rarely involves thyroid gland. Positron emission tomography–computed tomography (PET‐CT) may be critical in identifying thyroid…”
Get full text
Journal Article -
7
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron
Published in Antimicrobial Agents and Chemotherapy (01-01-2011)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
8
-
9
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis
Published in Antimicrobial agents and chemotherapy (01-10-2009)Get full text
Journal Article -
10
BEZ235: When Promising Science Meets Clinical Reality
Published in The oncologist (Dayton, Ohio) (01-09-2016)“…An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with advanced renal cell carcinoma. The…”
Get full text
Journal Article -
11
Sea-blue–colored histiocytes associated with bone marrow granulomas
Published in Blood (25-07-2013)Get full text
Journal Article -
12
Outcomes of Richter’s syndrome in patients with chronic lymphocytic leukemia (CLL) treated with platinum or anthracycline based chemotherapy with or without a BTK inhibitor (BTKi)
Published in Journal of clinical oncology (01-06-2022)“…e19511 Background: Richter’s syndrome (RS) is a rare complication of chronic lymphocytic leukemia (CLL) and the median survival is generally poor. Evidence is…”
Get full text
Journal Article -
13
Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma
Published in Blood and lymphatic cancer (31-07-2021)“…Advanced follicular lymphoma (FL) often relapses after front-line chemoimmunotherapy, and many patients will eventually require subsequent therapy. In 2021,…”
Get full text
Journal Article -
14
Outcomes in peripheral T-cell lymphomas: An analysis of patients treated at a single academic institution
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e19524 Background: T-cell lymphomas are a heterogeneous group of lymphomas, including the cutaneous T cell lymphoma (CTCL) and the peripheral T…”
Get full text
Journal Article -
15
Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma
Published in Cancers (01-02-2024)“…Chemoimmunotherapy and cellular therapy are the mainstay of the treatment of relapsed/refractory (R/R) lymphomas. Development of resistance and commonly…”
Get full text
Journal Article -
16
Safety and Efficacy of Belinostat Trial with Zidovudine Plus Interferon for HTLV-1 Related Adult T-Cell Leukemia-Lymphoma: Interim Results
Published in Blood (15-11-2022)Get full text
Journal Article -
17
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Published in Journal of clinical oncology (01-10-2021)“…We conducted a phase II study evaluating pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin (pembro-GVD) as second-line therapy for…”
Get full text
Journal Article -
18
Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate
Published in Leukemia & lymphoma (02-01-2022)Get full text
Journal Article -
19
Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies
Published in Cancers (10-10-2024)“…B-cell lymphoid malignancies are a heterogeneous group of hematologic cancers, where Bruton's tyrosine kinase (BTK) inhibitors have received FDA approval for…”
Get full text
Journal Article -
20
Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis
Published in Journal of the American Academy of Dermatology (01-08-2020)“…Mycosis fungoides (MF) is associated with increased risk of second primary hematologic malignancies, but its association with second primary solid tumors is…”
Get full text
Journal Article